News Archive

Pembrolizumab

EMA recommends pembrolizumab for the adjuvant treatment of RCC

EMA recommends pembrolizumab for the adjuvant treatment of RCC

EMA| Pembrolizumab

Urologytimes.com reports that the European Medicines Agency’s Committee for Medicinal Products for Human Use ...

NICE rejects pembro+axitinib therapy for aRCC

NICE rejects pembro+axitinib therapy for aRCC

Axitinib| NICE| Pembrolizumab

Kidney cancer community strongly disagrees with NICE decision not to approve pembrolizumab with axitinib ...

Researchers underscore efficacy of Pembrolizumab+Axitinib in treating advanced Rcc

Researchers underscore efficacy of Pembrolizumab+Axitinib in treating advanced Rcc

Axitinib| Pembrolizumab

ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell ...

Europe Adopts Pembrolizumab + Axitinib as 1st-Line Treatment for Advanced RCC

Europe Adopts Pembrolizumab + Axitinib as 1st-Line Treatment for Advanced RCC

Axitinib| Pembrolizumab

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), based in ...